Tumor Suppressors and Cell-Cycle Proteins in Lung Cancer

  • Baldi A
  • De Luca A
  • Esposito V
  • et al.
N/ACitations
Citations of this article
63Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The cell cycle is the cascade of events that allows a growing cell to duplicate all its components and split into two daughter cells. Cell cycle progression is mediated by the activation of a highly conserved family of protein kinases, the cyclin-dependent kinases (CDKs). CDKs are also regulated by related proteins called cdk inhibitors grouped into two families: the INK4 inhibitors (p16, p15, p19, and p18) and the Cip/Kip inhibitors (p21, p27, and p53). Several studies report the importance of cell-cycle proteins in the pathogenesis and the prognosis of lung cancer. This paper will review the most recent data from the literature about the regulation of cell cycle. Finally, based essentially on the data generated in our laboratory, the expression, the diagnostic, and prognostic significance of cell-cycle molecules in lung cancer will be examined.

Cite

CITATION STYLE

APA

Baldi, A., De Luca, A., Esposito, V., Campioni, M., Spugnini, E. P., & Citro, G. (2011). Tumor Suppressors and Cell-Cycle Proteins in Lung Cancer. Pathology Research International, 2011, 1–12. https://doi.org/10.4061/2011/605042

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free